Written by Max Bayer
June 15, 2022 Six days after the World Health Organization officially declared COVID-19 a global pandemic on March 11, 2020, Shafique Virani, M.D., landed a brand new job.
Following a two-year stint leading a couple of subsidiaries of BridgeBio, the Roche-Genentech alum jumped to Recursion Pharmaceuticals to be the chief corporate development officer of the AI-driven drug discovery company. Roughly two weeks later, the 2020 BIO International Convention was moved completely online. The tectonic plate shifts impacting society at large created a vacuum initially filled with uncertainty and unease. But soon after came an era of hyper-productivity, says Virani.
[Full article text: https://www.fiercebiotech.com/deals/after-three-years-away-bio-2022-marked-first-time-handshakes-and-drive-survive-bear-markets]